Use of virus as therapeutic agent, other than vaccine

Industry

CPC
C12N2710/24032

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C12Biochemistry C12NMICRO-ORGANISMS OR ENZYMES COMPOSITIONS THEREOF PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS MUTATION OR GENETIC ENGINEERING CULTURE MEDIA C12N2710/00dsDNA Viruses

Current Industry

C12N2710/24032Use of virus as therapeutic agent, other than vaccine

Industries

Patents Grantslast 30 patents

Information Patent Grant
Recombinant MVA or MVADELE3L expressing human FLT3L and use thereof...
- Patent number 12,036,279
- Issue date Jul 16, 2024
- Memorial Sloan Kettering Cancer Center
- Liang Deng
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Apoptotic upregulation by myxoma virus expressing walleye dermal sa...
- Patent number 11,591,616
- Issue date Feb 28, 2023
- Colorado State University Research Foundation
- Amy MacNeill
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-cancer oncolytic virus combination therapies and elite respond...
- Patent number 11,433,108
- Issue date Sep 6, 2022
- SUZHOU PRAJNA BIOTECH CO., LTD.
- Minjie Hu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Recombinant MVA or MVAΔE3L expressing human FLT3L and use thereof a...
- Patent number 11,285,209
- Issue date Mar 29, 2022
- Memorial Sloan Kettering Cancer Center
- Liang Deng
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Recombinant MVA or MVADELE3L expressing human FLT3L and use thereof...
- Patent number 10,736,962
- Issue date Aug 11, 2020
- Memorial Sloan Kettering Cancer Center
- Liang Deng
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Composition for treating cancerous cells and a method therefor
- Patent number 10,434,189
- Issue date Oct 8, 2019
- The Board of Trustees of Western Michigan University
- Karim Essani
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of a combination of Myxoma virus and rapamycin for therapeutic...
- Patent number 9,987,315
- Issue date Jun 5, 2018
- The University of Western Ontario
- Grant McFadden
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Myxoma virus mutants for cancer treatment
- Patent number 9,980,994
- Issue date May 29, 2018
- Robarts Research Institute
- John W. Barrett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Attenuated strain of myxoma virus for use as an oncolytic drug
- Patent number 8,613,915
- Issue date Dec 24, 2013
- Institute National de la Recherche Agronomique
- Stéphane Bertagnoli
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Myxoma virus mutants for cancer treatment
- Patent number 8,512,713
- Issue date Aug 20, 2013
- Robarts Research Institute
- John W. Barrett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of Myxoma virus for the therapeutic treatment of cancer and chr...
- Patent number 8,227,440
- Issue date Jul 24, 2012
- Robarts Research Institute
- Grant McFadden
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Monoparamunity inducers based on attenuated rabbit myxomaviruses
- Patent number 8,142,796
- Issue date Mar 27, 2012
- Bavarian Nordic A/S
- Anton Mayr
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of preparing myxomavirus compositions
- Patent number 8,039,004
- Issue date Oct 18, 2011
- Bavarian Nordic A/S
- Anton Mayr
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Monoparamunity inducers based on attenuated rabbit myxoma viruses
- Patent number 8,034,356
- Issue date Oct 11, 2011
- Bavarian Nordic A/S
- Anton Mayr
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Monoparamunity inducers based on attenuated rabbit myxomaviruses
- Patent number 7,939,085
- Issue date May 10, 2011
- Bavarian Nordic A/S
- Anton Mayr
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Monoparamunity inducers based on attenuated rabbit myxomaviruses
- Patent number 7,691,391
- Issue date Apr 6, 2010
- Bavarian Nordic A/S
- Anton Mayr
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of myxoma virus for the therapeutic treatment of cancer and chr...
- Patent number 7,582,614
- Issue date Sep 1, 2009
- Robarts Research Institute
- Grant McFadden
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Paramunity inducers based on attenuated rabbit myxoma virus
- Patent number 7,494,799
- Issue date Feb 24, 2009
- Bavarian Nordic A/S
- Anton Mayr
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of poxviruses as enhancer of specific immunity
- Patent number 6,641,816
- Issue date Nov 4, 2003
- Aventis Pasteur S.A.
- Michel Chevalier
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
COMPOSITION AND METHODS INCLUDING RECOMBINANT VIRUSES MODULATING AR...
- Publication number 20240316130
- Publication date Sep 26, 2024
- UNM Rainforest Innovations
- Eric Bartee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ONCOLYTIC VIRUSES THAT EXPRESS MULTI-SPECIFIC IMMUNE CELL ENGAGERS
- Publication number 20240093158
- Publication date Mar 21, 2024
- Arizona Board of Regents on behalf of Arizona State University
- Douglas Grant MCFADDEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RECOMBINANT MVA OR MVADELE3L EXPRESSING HUMAN FLT3L AND USE THEREOF...
- Publication number 20230057304
- Publication date Feb 23, 2023
- Memorial Sloan-Kettering Cancer Center
- Liang DENG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ONCOLYTIC MYXOMA VIRUS EXPRESSING FAST P14 TO TREAT HEMATOLOGICAL C...
- Publication number 20220088096
- Publication date Mar 24, 2022
- ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA, ACTING FOR
- Douglas Grant McFADDEN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ONCOLYTIC VIRUS PLATFORM TO TREAT HEMATOLOGICAL CANCER
- Publication number 20210252086
- Publication date Aug 19, 2021
- Arizona Board of Regents on behalf of Arizona State University
- Douglas Grant MCFADDEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RECOMBINANT MVA OR MVADELE3L EXPRESSING HUMAN FLT3L AND USE THEREOF...
- Publication number 20200316198
- Publication date Oct 8, 2020
- Memorial Sloan-Kettering Cancer Center
- Liang DENG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ONCOLYTIC VIRUS EXPRESSING A CAR T CELL TARGET AND USES THEREOF
- Publication number 20200215132
- Publication date Jul 9, 2020
- CITY OF HOPE
- Yuman Fong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITION FOR TREATING CANCEROUS CELLS AND A METHOD THEREFOR
- Publication number 20200114024
- Publication date Apr 16, 2020
- The Board of Trustees of Western Michigan Univeraity
- Karim Essani
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF A COMBINATION OF MYXOMA VIRUS AND RAPAMYCIN FOR THERAPEUTIC...
- Publication number 20180256656
- Publication date Sep 13, 2018
- The University of Western Ontario
- Douglas Grant McFadden
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MYXOMA VIRUS MUTANTS FOR CANCER TREATMENT
- Publication number 20160136212
- Publication date May 19, 2016
- Robarts Research Institute
- John W. BARRETT
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF A COMBINATION OF MYXOMA VIRUS AND RAPAMYCIN FOR THERAPEUTIC...
- Publication number 20140134134
- Publication date May 15, 2014
- GRANT MCFADDEN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MYXOMA VIRUS MUTANTS FOR CANCER TREATMENT
- Publication number 20130336930
- Publication date Dec 19, 2013
- Robarts Research Institute
- John W. BARRETT
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF A COMBINATION OF MYXOMA VIRUS AND RAPAMYCIN FOR THERAPEUTIC...
- Publication number 20130171106
- Publication date Jul 4, 2013
- Robarts Research Institute
- Grant McFadden
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Attenuated Strain of Myxoma Virus for Use as an Oncolytic Drug
- Publication number 20120141427
- Publication date Jun 7, 2012
- Stéphane Bertagnoli
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MONOPARAMUNITY INDUCERS BASED ON ATTENUATED RABBIT MYXOMAVIRUSES
- Publication number 20120070464
- Publication date Mar 22, 2012
- Anton Mayr
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MONOPARAMUNITY INDUCERS BASED ON ATTENUATED RABBIT MYXOMAVIRUSES
- Publication number 20120009654
- Publication date Jan 12, 2012
- Anton Mayr
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MONOPARAMUNITY INDUCERS BASED ON ATTENUATED RABBIT MYXOMAVIRUSES
- Publication number 20120009217
- Publication date Jan 12, 2012
- Anton Mayr
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF A COMBINATION OF MYXOMA VIRUS AND RAPAMYCIN FOR THERAPEUTIC...
- Publication number 20110195050
- Publication date Aug 11, 2011
- Robarts Research Institute
- Grant McFadden
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MYXOMA VIRUS MUTANTS FOR CANCER TREATMENT
- Publication number 20110158945
- Publication date Jun 30, 2011
- ROBARTS RESEARCH INSTITUTE
- John W. Barrett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MONOPARAMUNITY INDUCERS BASED ON ATTENUATED RABBIT MYXOMA VIRUSES
- Publication number 20110020908
- Publication date Jan 27, 2011
- Anton Mayr
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MONOPARAMUNITY INDUCERS BASED ON ATTENUATED RABBIT MYXOMA VIRUSES
- Publication number 20110014234
- Publication date Jan 20, 2011
- Anton Mayr
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MONOPARAMUNITY INDUCERS BASED ON ATTENUATED RABBIT MYXOMAVIRUSES
- Publication number 20100316671
- Publication date Dec 16, 2010
- Anton Mayr
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF MYXOMA VIRUS FOR THE THERAPEUTIC TREATMENT OF CANCER AND CHR...
- Publication number 20090317362
- Publication date Dec 24, 2009
- Wellstat Biologics Corporation
- Grant McFadden
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF A COMBINATION OF MYXOMA VIRUS AND RAPAMYCIN FOR THERAPEUTIC...
- Publication number 20090035276
- Publication date Feb 5, 2009
- ROBARTS RESEARCH INSTITUTE
- Grant McFadden
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MONOPARAMUNITY INDUCERS BASED ON ATTENUATED RABBIT MYXOMAVIRUSES
- Publication number 20080267920
- Publication date Oct 30, 2008
- Anton Mayr
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MONOPARAMUNITY INDUCERS BASED ON ATTENUATED RABBIT MYXOMAVIRUSES
- Publication number 20080213307
- Publication date Sep 4, 2008
- Anton Mayr
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Poxvirus Vector Encoding Prostate Specific Antigens For Treatment O...
- Publication number 20070196346
- Publication date Aug 23, 2007
- Michael Paul Brown
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Monoparamunity inducers based on attenuated rabbit myxoma viruses
- Publication number 20070154455
- Publication date Jul 5, 2007
- Anton Mayr
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of myxoma virus for the therapeutic treatment of cancer and chr...
- Publication number 20060263333
- Publication date Nov 23, 2006
- Grant McFadden
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Use of virus as therapeutic agent, other than vaccine

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Recombinant MVA or MVADELE3L expressing human FLT3L and use thereof...

Apoptotic upregulation by myxoma virus expressing walleye dermal sa...

Anti-cancer oncolytic virus combination therapies and elite respond...

Recombinant MVA or MVAΔE3L expressing human FLT3L and use thereof a...

Recombinant MVA or MVADELE3L expressing human FLT3L and use thereof...

Composition for treating cancerous cells and a method therefor

Use of a combination of Myxoma virus and rapamycin for therapeutic...

Myxoma virus mutants for cancer treatment

Attenuated strain of myxoma virus for use as an oncolytic drug

Myxoma virus mutants for cancer treatment

Use of Myxoma virus for the therapeutic treatment of cancer and chr...

Monoparamunity inducers based on attenuated rabbit myxomaviruses

Methods of preparing myxomavirus compositions

Monoparamunity inducers based on attenuated rabbit myxoma viruses

Monoparamunity inducers based on attenuated rabbit myxomaviruses

Monoparamunity inducers based on attenuated rabbit myxomaviruses

Use of myxoma virus for the therapeutic treatment of cancer and chr...

Paramunity inducers based on attenuated rabbit myxoma virus

Use of poxviruses as enhancer of specific immunity

Patents Applicationslast 30 patents

COMPOSITION AND METHODS INCLUDING RECOMBINANT VIRUSES MODULATING AR...

ONCOLYTIC VIRUSES THAT EXPRESS MULTI-SPECIFIC IMMUNE CELL ENGAGERS

RECOMBINANT MVA OR MVADELE3L EXPRESSING HUMAN FLT3L AND USE THEREOF...

ONCOLYTIC MYXOMA VIRUS EXPRESSING FAST P14 TO TREAT HEMATOLOGICAL C...

ONCOLYTIC VIRUS PLATFORM TO TREAT HEMATOLOGICAL CANCER

RECOMBINANT MVA OR MVADELE3L EXPRESSING HUMAN FLT3L AND USE THEREOF...

ONCOLYTIC VIRUS EXPRESSING A CAR T CELL TARGET AND USES THEREOF

COMPOSITION FOR TREATING CANCEROUS CELLS AND A METHOD THEREFOR

USE OF A COMBINATION OF MYXOMA VIRUS AND RAPAMYCIN FOR THERAPEUTIC...

MYXOMA VIRUS MUTANTS FOR CANCER TREATMENT

USE OF A COMBINATION OF MYXOMA VIRUS AND RAPAMYCIN FOR THERAPEUTIC...

MYXOMA VIRUS MUTANTS FOR CANCER TREATMENT

USE OF A COMBINATION OF MYXOMA VIRUS AND RAPAMYCIN FOR THERAPEUTIC...

Attenuated Strain of Myxoma Virus for Use as an Oncolytic Drug

MONOPARAMUNITY INDUCERS BASED ON ATTENUATED RABBIT MYXOMAVIRUSES

MONOPARAMUNITY INDUCERS BASED ON ATTENUATED RABBIT MYXOMAVIRUSES

MONOPARAMUNITY INDUCERS BASED ON ATTENUATED RABBIT MYXOMAVIRUSES

USE OF A COMBINATION OF MYXOMA VIRUS AND RAPAMYCIN FOR THERAPEUTIC...

MYXOMA VIRUS MUTANTS FOR CANCER TREATMENT

MONOPARAMUNITY INDUCERS BASED ON ATTENUATED RABBIT MYXOMA VIRUSES

MONOPARAMUNITY INDUCERS BASED ON ATTENUATED RABBIT MYXOMA VIRUSES

MONOPARAMUNITY INDUCERS BASED ON ATTENUATED RABBIT MYXOMAVIRUSES

USE OF MYXOMA VIRUS FOR THE THERAPEUTIC TREATMENT OF CANCER AND CHR...

USE OF A COMBINATION OF MYXOMA VIRUS AND RAPAMYCIN FOR THERAPEUTIC...

MONOPARAMUNITY INDUCERS BASED ON ATTENUATED RABBIT MYXOMAVIRUSES

MONOPARAMUNITY INDUCERS BASED ON ATTENUATED RABBIT MYXOMAVIRUSES

Poxvirus Vector Encoding Prostate Specific Antigens For Treatment O...

Monoparamunity inducers based on attenuated rabbit myxoma viruses

Use of myxoma virus for the therapeutic treatment of cancer and chr...